Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Investigational drug tested for preventing muscle fiber death in muscular dystrophy

Investigational drug tested for preventing muscle fiber death in muscular dystrophy

March 17, 2008

Study in mice identifies possible new treatment strategy for MD

CINCINNATI - An investigational antiviral drug currently undergoing human trials in Europe for treating Hepatitis C infections may have potential to reduce muscle cell damage in Duchenne and other forms of muscular dystrophy (MD). A research team led by Cincinnati Children's Hospital Medical Center reported their results using three different mouse models of MD in a letter posted online March 16 by the journal Nature Medicine.




The investigational drug, Debio-025, is a known inhibitor of the protein cyclophilin D, which regulates the swelling of mitochondria in response to cellular injury. Researches decided to test the drug in mice engineered to carry MD after earlier laboratory tests showed deleting a gene that encodes cycolphilin D reduced swelling and reversed or prevented the disease's muscle-damaging characteristics. The mice were engineered as models of Duchenne muscular dystrophy and forms caused by a deficiency of two structural proteins, delta-sarcoglycan and laminin alpha2.

"Similar to deleting the gene encoding cyclophilin D, we found that treatment with Debio-025 reduced mitochondrial swelling and necrotic manifestations in mice with muscular dystrophy. This is why we believe inhibiting cyclophilin D could be a new treatment strategy," said Jeff Molkentin, Ph.D., corresponding author of the study and a researcher in the Division of Molecular Cardiovascular Biology at Cincinnati Children's. "Debio-025 has already passed Phase II clinical trials in Europe and is considered safe in people, so we want to explore the possibility of conducting clinical trials in patients with Duchenne MD."

During the onset of muscular dystrophy, the loss of certain proteins critical to muscle function - such as dystrophin - can lead to contraction-related micro-tears in muscle fibers and an influx of calcium around muscle tissue. When this happens, cyclophilin D is instructed to make the membranes of mitochondria more permeable. This causes mitochondria to be flooded by calcium and reorganize, swell and eventually rupture. This triggers cell death in muscle fibers and leads to the progressive muscle weakness, wasting and often early death associated with muscular dystrophy.

Mice lacking the protein delta-sarcoglycan exhibited severe dystrophy and swelling in both skeletal and heart muscle. When Dr. Molkentin and his colleagues deleted the gene encoding cyclophilin D in these mice, the muscle cells returned to near normal and did not show appreciable signs of swelling and cell death. The investigators repeated the experiment with mice lacking a gene encoding laminin alpha2, which causes a more severe dystrophy, swollen skeletal muscle cells and premature death before the mice reach two months of age. In contrast, mice lacking both laminin alpha2 and cyclophilin D showed much healthier muscle cells, increased body weight and walked more. Also, 75 percent of the mice lacking laminin alpha2 and cyclophilin D lived more than three times longer than mice lacking only laminin alpha2.

These findings led the research team to look for pharmacological treatments that also could inhibit cyclophilin D. The drug cyclosporine is a well-documented inhibitor of the protein, but its use is problematic because it also inhibits a protein, calcineurin, crucial to skeletal muscle cell repair after injury and to the development of skeletal muscle cells. The advantage of Debio-025 is that while it inhibits cyclophilin D and blocks cell death in a number of situations, the drug does not suppress the immune system or block calcineurin. The drug is manufactured by DebioPharm S.A. of Lausanne, Switzerland, which provided Debio-025 for use in the study.

The researchers also found their study may have implications beyond skeletal muscle disease as cyclophilin D deletion reduced cardiac dysfunction caused by calcium-overload induced necrosis. This led the team to suggest that mitochondrial-dependent necrosis may also function as a common disease mechanism underlying a number of long-term degenerative disorders, something they plan to study in future research projects.

Muscular dystrophies are inherited disorders that mostly affect striated muscle tissue and more commonly occur in boys. This disease results in progressive muscle weakness, wasting and in many instances death. There is no known cure for muscular dystrophy, although Cincinnati Children's is a recognized leader in disease-related research and a multi-disciplinary approach to patient treatment focused on maximizing ambulatory function and quality of life.

Cincinnati Children's Hospital Medical Center



Related Muscular Dystrophy Current Events and Muscular Dystrophy News Articles Muscular Dystrophy Current Events and Muscular Dystrophy News RSS Muscular Dystrophy Current Events and Muscular Dystrophy News RSS
Treatment to improve degenerating muscle gains strength
A study appearing in Science Translational Medicine puts scientists one step closer to clinical trials to test a gene delivery strategy to improve muscle mass and function in patients with certain degenerative muscle disorders.

Possible help in fight against muscle-wasting disease
A compound already used to treat pneumonia could become a new therapy for an inherited muscular wasting disease, according to researchers at the University of Oregon and the University of Rochester School of Medicine and Dentistry in New York.

Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice
An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan.

To regenerate muscle, cellular garbage men must become builders
For scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, what seemed like a disappointing result turned out to be an important discovery.

Zoo volunteers help explain mysteries of the genome
As the University of Leicester approaches the 25th anniversary of the discovery of DNA fingerprinting (September 10), Leicester geneticists interested in a particular type of DNA are receiving some help from an unusual band of assistants.

Small molecule inhibits pathology associated with myotonic dystrophy type 1
Researchers at the University of Illinois have designed a small molecule that blocks an aberrant pathway associated with myotonic dystrophy type 1, the most common form of muscular dystrophy.

Researchers identify new function for protein missing in Duchenne muscular dystrophy
Researchers at the University of Minnesota and National Institutes of Health have identified a new function for the protein missing in people with the most common and ultimately lethal form of childhood muscular dystrophy.

Sticky protein helps reinforce fragile muscle membranes
A new study by scientists at the University of Iowa shows why muscle membranes don't rupture when healthy people exercise.

Stem cell surprise for tissue regeneration
Scientists working at the Carnegie Institution's Department of Embryology, with colleagues, have overturned previous research that identified critical genes for making muscle stem cells.

Researchers make progress toward early identification of muscular dystrophy
The saying "Knowing is half the battle" is never more true than when discussing early treatment of disease. Muscular dystrophy is one such disease where patients can benefit from early treatment. Now, new research is moving doctors and scientists closer to disease diagnosis in advance of patient symptoms.
More Muscular Dystrophy Current Events and Muscular Dystrophy News Articles
Muscular Dystrophy (The Facts)

Muscular Dystrophy (The Facts)
by Alan E.H. Emery (Author)

The muscular dystrophies are a group of genetic diseases that severely affect children and adults. For sufferers and their family, the illness presents enormous physical and psychological challenges. Written specifically for people with muscular dystrophy and their families, this book answers many of the questions asked about how and why muscular dystrophy occurs, and how it will affect the life of a recently diagnosed child.

As well as presenting the reader with advice and an explanation of muscular dystrophy, the book also guides the reader towards further information on societies and support groups around the world, and reliable internet resources. It also contains a full glossary to aid the reader in their understanding of the disease.

The different types of...

Muscular Dystrophy (Diseases and Disorders)

Muscular Dystrophy (Diseases and Disorders)
by Melissa Abramovitz (Author)



Muscular Dystrophy in Children: A Guide for Families

Muscular Dystrophy in Children: A Guide for Families
by Irwin M. Siegel (Author)

Written for children with muscular dystrophy (MD) and their families, friends and teachers, this book is a guide through the often-frightening labyrinth of medical care that follows the diagnosis of MD. Forthright, clear, supportive and empowering, the book helps readers understand the significance of the signs and symptoms of the disease, treatment options, the disease's probable course and what may affect it, and choices in directing therapy. This incomparable guide covers:
*

The diagnosis of childhood muscular dystrophy
*

Early childhood
*

Prepuberty
*

Fractures
*

Adolescence
*

Late problems
*

Caregiver's self-help guide
*

New research
*

Suggestions for further reading.
Filled with state-of-the-art...

Muscular Dystrophy: theFacts

Muscular Dystrophy: theFacts
by Alan Emery (Author)

European Neuromuscular Centre, Baarn, The Netherlands. Discusses living with muscular dystrophy and coping with its physical effects. Written for people with this illness and their families, it answers many questions asked by those diagnosed with muscular dystrophy. Previous edition: c1994. Softcover.

Muscular Dystrophy (Genetic and Developmental Diseases and Disorders)

Muscular Dystrophy (Genetic and Developmental Diseases and Disorders)
by Paula Johanson (Author)



TRI WRITE CRAYONS

TRI WRITE CRAYONS
by The Sensory University

In the late 1980's David Chesar discovered the initial TriWrite product design in his seventh grade science project. The initial project's goal was to find a crayon shape that would improve a child's writing grasp and hand writing skills. The success of the first project sparked his curiosity and subsequent science fair projects. During these projects, grips and crayons were developed to help the average writer, the elderly writer and physically and mentally challenged writers. Marked handwriting improvements occurred in all groups. As word spread, and various awards were won, many individuals requested David's product for their children just beginning to write, their parents suffering from a hand injury, or even their grandparents with arthritis. As a result of growing product demand,...

Christmas Crackers

Christmas Crackers
Muscular Dystrophy (Primary Contributor)



Yog For Muscular Dystrophy

Yog For Muscular Dystrophy
Starring: Swami Ramdev
Directed By: Swami Ramdev

This DVD contains Pranayams, Yog assanas, Acupressure and Home remedies for Muscular Dystrophy. Treatment through yog, ayurved,accupressure and domestic remedies for diseases like cerebral palsy, muscular dystrophy, mongolism, multiple sclerosis and thalassemia. Millions of children in the country have faced disability due to consumption of strong medicines by pregnant mothers and other factors such as a child not crying at the time of birth. Our treatment and experience has shown that children suffering from muscular dystrophy have been cured in almost two years through constant practice of pranayam. The CT, blood count of patients has come to normal and those suffering from multiple sclerosis have also been cured. Young generation between 25 to 35 years of age should be free from all...

My Buddy (An Owlet Book)

My Buddy (An Owlet Book)
by Audrey Osofsky (Author), Ted Rand (Illustrator)

Buddy is the best dog a boy could have. He and his master are always together. They play ball, and go for walks, and take good care of each other. Nothing can separate them. They're a team.


Muscular Dystrophy Awareness Ribbon Mouse Pad

Muscular Dystrophy Awareness Ribbon Mouse Pad
by MyHeritageWear.com

The Muscular Dystrophy Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Muscular Dystrophy Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Muscular Dystrophy Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness!

© 2009 BrightSurf.com